Companies: 10,795·Total market cap: $144.5T
ProPhase Labs, Inc.

ProPhase Labs, Inc.

PRPHNASDAQHealthcare● Active
$0.10
$-0.01(-9.09%)
Market Cap$473701
P/E Ratio
52W High$6.7
52W Low$0.07
Overview

ProPhase Labs, Inc.(PRPH)股价预测与分析师目标价

华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。

prph · 股价预测 · 2 位分析师(近3月)· FMP · 更新于 2026年6月9日

分析师评级与共识

基于过去 3 个月内 2 位华尔街分析师

SellBuy

Buy

2 位分析师

共识

评级分布

Strong Buy
0
Buy
1
Hold
1
Sell
0
Strong Sell
0
合计: 2 · 买入占比: 50.0%

12 个月目标价

High

$140

Consensus

$140

+139900.0% upside

Low

$140

Median: $140 · Last Close: $0.10

ProPhase Labs, Inc.(PRPH)的分析师共识为 Buy,基于过去 3 个月内 2 位华尔街分析师的评级。PRPH 的 12 个月平均目标价为 $140.00,相对当前价 $0.10 代表 +139900.0% 的潜在上行空间。

12 个月目标价预测

历史收盘价 + 分析师 12 个月目标价预测区间

分析师目标价覆盖不足,无法为该股票生成预测图表。

短期股价预测

算法生成 · 每日更新

DatePredicted PriceChange
2026-06-10$0.115.00%

1-day model range: $0.1–$0.11. Peak: $0.11 (+5.00%).

长期股价预测

⚠️ 在满 252 个交易日历史(IPO/上市时间较短)前不展示长期预测;短期标签页仍可能显示模型输出。

基于技术分析的股价预测

14 项技术面信号(SMA×6 + EMA×6 + RSI + MACD)· EEAT 方法论透明

Market Sentiment

BEARISH

Based on 14 technical indicators

0%36%64%
0Buy
5Neutral
9Sell
RSI (14)46.5Neutral
MACDBEARISH

Refreshes daily from EOD close

Moving Averages · PRPH · Jun 9, 2026

Simple Moving Average (SMA)
MA 5$0.12SELL
MA 10$0.11SELL
MA 20$0.11SELL
MA 50$0.11SELL
MA 100$0.00NEUTRAL
MA 200$0.00NEUTRAL
Current $PRPH · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$0.11SELL
EMA 10$0.11SELL
EMA 20$0.11SELL
EMA 50$0.12SELL
EMA 100$0.00NEUTRAL
EMA 200$0.00NEUTRAL
Current $PRPH · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

最新分析师评级与调整

Filter:
HC Wainwright & Co.2024-02-21
Maintains
BuyBuy
HC Wainwright & Co.2023-11-10
Maintains
BuyBuy
HC Wainwright & Co.2023-08-14
Maintains
BuyBuy
HC Wainwright & Co.2023-06-02
Maintains
BuyBuy
HC Wainwright & Co.2023-05-12
Maintains
BuyBuy
HC Wainwright & Co.2023-03-08
Maintains
BuyBuy
HC Wainwright & Co.2023-02-23
Maintains
BuyBuy
HC Wainwright & Co.2023-02-16
Maintains
BuyBuy
HC Wainwright & Co.2023-02-07
Maintains
BuyBuy
HC Wainwright & Co.2022-11-11
Maintains
BuyBuy

Wall Street analysts have recently issued updated ratings on ProPhase Labs, Inc. (PRPH) stock. Of the recent 15 rating actions, 0 were upgrades and 1 were downgrades. 2 analysts currently cover PRPH.

分析师推荐趋势

Buy ratings11
Hold ratings00
Sell ratings00

PRPH analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.

财务预测:EPS 与营收一致预期

Revenue This Year

$121M

↑ 832.0% YoY

Revenue Next Year

$18M

↓ 85.2% YoY

EPS This Year

$1.12

EPS Next Year

$-1.46

↓ 230.2% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast PRPH EPS of $1.12 for the current fiscal year, based on estimates from 1 analysts. The PRPH revenue forecast is $121M for the current year. These are analyst consensus estimates via FMP / S&P Global.

关于预测与目标价

PRPH 股价预测由两类独立数据源支撑:来自 2 位华尔街分析师(S&P Global / FMP)的共识评级,以及基于历史日终价计算的技术分析。PRPH 的共识目标价为 $140.00(+139900.0% 上行空间),分析师共识为 Buy。

PRPH 的短期预测(明日)为 $0.11(+5.00%)。

ProPhase Labs, Inc. 在 NASDAQ 上市,代码 PRPH。PRPH 在 2027 年的整体展望偏积极,在覆盖分析师中约 50% 对应 Buy 共识。

常见问题答案综合分析师目标价、一致预期及页面展示的模型结果。

常见问题

PRPH 预测 · 8 个问题

根据 2 位华尔街分析师,PRPH 的 12 个月平均目标价为 $140.00,最高 $140.00、最低 $140.00。若有图表,中位目标价可在上方查看。相对当前价 $0.10,隐含约 +139900.0% 的上行空间。

PRPH 目标价PRPH 分析师目标价PRPH 12个月目标价目标价 PRPH

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.